Concepedia

T. A. Andreeva

TA

Statistics

Publications

7

Citations

345

H-Index

7

Active since

1983

Affiliations

University of the Witwatersrand(Current)

Mount Sinai Hospital

National Medical Research Center for Hematology

Indiana Hemophilia and Thrombosis Center

T. A. Andreeva is an author at University of the Witwatersrand specializing in inflammation, medicine, and hematology.

ORCID

Top concepts

Publications per year

1983–2022

7

Publications

7

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A

Paul Giangrande, T. A. Andreeva, Pratima Chowdary et al. · Thrombosis and Haemostasis · 2016 · 114 citations

Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A

Robert Klamroth, Gregory M. Hayes, T. A. Andreeva et al. · Human Gene Therapy · 2022 · 95 citations · Full text

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

W. Kreuz, Carmen Escuriola Ettingshausen, Vladimír Vdovin et al. · Haemophilia · 2015 · 56 citations · Full text

Recombinant B‐domain‐deleted porcine sequence factor <scp>VIII</scp> (r‐<scp>pFVIII</scp>) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors

Johnny Mahlangu, T. A. Andreeva, Donald E. Macfarlane et al. · Haemophilia · 2016 · 25 citations · Full text

[Unsolved therapeutic problems of hemophilia].

T. A. Andreeva · PubMed · 1983 · 24 citations

, , +2

1–5 of 7